Long-Term Impact of the Dutch Colorectal Cancer Screening Program on Cancer Incidence and Mortality-Model-Based Exploration of the Serrated Pathway

被引:24
|
作者
Greuter, Marjolein J. E. [1 ]
Demirel, Erhan [1 ]
Lew, Jie-Bin [2 ,3 ]
Berkhof, Johannes [1 ]
Xu, Xiang-Ming [2 ,3 ]
Canfell, Karen [2 ,3 ]
Dekker, Evelien [4 ]
Meijer, Gerrit A. [5 ]
Coupe, Veerle M. H. [1 ]
机构
[1] Vrije Univ Amsterdam, Med Ctr, Dept Epidemiol & Biostat, POB 7057,MF F Wing, NL-1007 MB Amsterdam, Netherlands
[2] Univ NSW, Lowy Canc Res Ctr, Sydney, NSW, Australia
[3] Univ NSW, Lowy Canc Res Ctr, Prince Wales Clin Sch, Sydney, NSW, Australia
[4] Univ Amsterdam, Acad Med Ctr, Dept Gastroenterol & Hepatol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands
[5] Vrije Univ Amsterdam, Med Ctr, Dept Pathol, NL-1007 MB Amsterdam, Netherlands
基金
英国医学研究理事会;
关键词
RANDOMIZED CONTROLLED-TRIAL; OCCULT BLOOD-TESTS; HYPERPLASTIC POLYPS; IMMUNOCHEMICAL TEST; COLON; COLONOSCOPY; ADENOMA; CLASSIFICATION; POPULATION; ROUNDS;
D O I
10.1158/1055-9965.EPI-15-0592
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: We aimed to predict the long-term colorectal cancer incidence, mortality, and colonoscopy demand of the recently implemented Dutch colorectal cancer screening program. Methods: The Adenoma and Serrated pathway to Colorectal Cancer model was set up to simulate the Dutch screening program consisting of biennial fecal immunochemical testing combined with the new Dutch surveillance guidelines, between 2014 and 2044. The impact of screening and surveillance was evaluated under three sets of natural history assumptions differing in the contribution of the serrated pathway to colorectal cancer incidence. In sensitivity analyses, other assumptions concerning the serrated pathway were varied. Model-predicted outcomes were yearly colorectal cancer incidence, mortality, and colonoscopy demand per year. Results: Assuming an aging population, colorectal cancer incidence under 30 years of screening is predicted to decrease by 35% and 31% for a contribution of 0% and 30% of the serrated pathway to colorectal cancer, respectively. For colorectal cancer mortality, reductions are 47% and 45%. In 2044, 110,000 colonoscopies will be required annually assuming no contribution of the serrated pathway (27 per 1,000 individuals in the screening age range). Including the serrated pathway influences predicted screening effectiveness if serrated lesions are neither detected nor treated at colonoscopy, and/or if colorectal cancers arising from serrated lesions have substantially lower survival rates than those arising from adenomas. Conclusions: The Dutch screening program will markedly decrease colorectal cancer incidence and mortality but considerable colonoscopy resources will be required. Impact: Predictions of long-term screening effectiveness are preferably based on both pathways to colorectal cancer to transparently describe the impact of uncertainties regarding the serrated pathway on long-term predictions. (C) 2015 AACR.
引用
收藏
页码:135 / 144
页数:10
相关论文
共 50 条
  • [21] COLORECTAL CANCER INCIDENCE AND MORTALITY REDUCTION IN THE CZECH REPUBLIC - IMPACT OF THE LONGLASTING NATIONAL SCREENING PROGRAM?
    Suchanek, Stepan
    Ngo, Ondrej
    Grega, Tomas
    Hejcmanova, Katerina
    Chloupkova, Renata
    Ambrozova, Monika
    Majek, Ondrej
    Zavoral, Miroslav
    GASTROENTEROLOGY, 2023, 164 (06) : S987 - S987
  • [22] IMPACT OF THE ORGANIZED SCREENING PROGRAM IN THE CZECH REPUBLIC ON THE COLORECTAL CANCER INCIDENCE AND MORTALITY AND THE EFFECT OF THE TRANSITION TO THE POPULATION-BASED PROGRAM
    Suchanek, Stepan
    Tomas, Grega
    Majek, Ondrej
    Ngo, Ondrej
    Seifert, Bohumil
    Dusek, Ladislav
    Zavoral, Miroslav
    GASTROENTEROLOGY, 2017, 152 (05) : S544 - S544
  • [23] Effect of flexible sigmoidoscopy screening on colorectal cancer incidence and mortality: long-term follow-up of the randomised US PLCO cancer screening trial
    Miller, Eric A.
    Pinsky, Paul F.
    Schoen, Robert E.
    Prorok, Philip C.
    Church, Timothy R.
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2019, 4 (02): : 101 - 110
  • [24] Long-term colorectal cancer incidence and mortality after adenoma removal in women and men
    Jodal, Henriette C.
    Klotz, Dagmar
    Herfindal, Magnhild
    Barua, Ishita
    Tag, Petter
    Helsingen, Lise M.
    Refsum, Erle
    Holme, Oyvind
    Adami, Hans-Olov
    Bretthauer, Michael
    Kalager, Mette
    Loberg, Magnus
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 55 (04) : 412 - 421
  • [25] Statin therapy: long-term mortality and cancer incidence
    Nature Clinical Practice Oncology, 2004, 1 (1): : 7 - 8
  • [26] Long-Term Prediction of the Demand of Colonoscopies Generated by a Population-Based Colorectal Cancer Screening Program
    Comas, Merce
    Mendivil, Joan
    Andreu, Montserrat
    Hernandez, Cristina
    Castells, Xavier
    PLOS ONE, 2016, 11 (10):
  • [27] Colorectal cancer: Screening provides long-term benefits
    Sidaway P.
    Nature Reviews Clinical Oncology, 2017, 14 (5) : 262 - 262
  • [28] Impact of Screening-related Sigmoidoscopy on the Incidence and Mortality of Colorectal Cancer
    Forbes, Nauzer
    GASTROENTEROLOGY, 2023, 165 (03) : 802 - 802
  • [29] Quantifying the impact of adherence to screening strategies on colorectal cancer incidence and mortality
    D'Andrea, Elvira
    Ahnen, Dennis J.
    Sussman, Daniel A.
    Najafzadeh, Mehdi
    CANCER MEDICINE, 2020, 9 (02): : 824 - 836
  • [30] Impact of Screening Program on Incidence of Colorectal Cancer: A Cohort Study in Italy
    Rossi, Paolo Giorgi
    Vicentini, Massimo
    Sacchettini, Claudio
    Di Felice, Enza
    Caroli, Stefania
    Ferrari, Francesca
    Mangone, Lucia
    Pezzarossi, Annamaria
    Roncaglia, Francesca
    Campari, Cinzia
    Sassatelli, Romano
    Sacchero, Roberto
    Sereni, Giuliana
    Paterlini, Luisa
    Zappa, Marco
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 (09): : 1359 - 1366